HUM-MOLGEN events: Business of Biotech Symposium and Expo

HUM-MOLGEN -> Events -> Meetings and Conferences

August 14, 2003

Strategic Research Institute, 333 7th Ave, 9th Floor
Sept 28-29, 2003

This year’s program will examine, analyze, update, debate, explore and discuss all aspects of this dynamic and important market. Through presentations, roundtable discussions, debates and workshops, we will address the most critical issues facing the biotech community today, including:

-Investors’ expectations in today’s climate
-Survival tips in a bear market
-Alternative ways to raise capital
-The changing nature of the CEO’s role
-Product marketing & sales strategies for competitive advantage
-Decreasing clinical trial costs
-Designing optimum licensing deals
-Enhancing your worth in merger, acquisition, and consolidation deals
-Outsourcing resources
-Maximizing deal value between biotech and pharma
-Trends affecting the future of drug development and commercialization
-Exit strategies
-Case studies from leading biotech firms

Organized by:

Strategic Research Institute

Invited Speakers:

Confirmed participants from the investment community include:
Forward Ventures
Lilly BioVentures
TVM Techno Venture Management
Sofinnova Ventures
Domain Associates
Castle Creek LifeScience Partners
California Techonology Ventures
Alta Partners
Ventana Capital Management
Orbimed Advisors
San Diego Tech Coast Angels
A. M. Pappas & Associates
HOTventures LLC
HamiltonApex Ventures

Deadline for Abstracts:

Sept 29, 2003

Registration:

$1,695.00 Advisor/Service Provider $1,495.00 Investor/Pharma $1,195.00 Biotechs/Academic/Government $190.00 Networking Activity on 9/29: GOLF $35.00 Networking Activity on 9/29: TENNIS

E-mail:

ipakoys@srinstitute.com

Posted by:

Ilana Pakoys

Host:

sricom.srinstitute.com

home

genetic news

bioinformatics

biotechnology

literature

journals

ethics

positions

events

sitemap